BlossomHill Therapeutics Inc.
BLSM | NASDAQ
$26.80
+$1.06 (+4.12%)
At close: Sep 21, 2026, 4:00 PM ET
$26.14
-$0.66 (-2.46%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 |
|---|---|---|
Revenue | n/a | n/a |
Cost of Revenue | n/a | n/a |
Gross Profit | n/a | n/a |
Operating Income | -64.02M | -36.4M |
Interest Income | 3.48M | 5.71M |
Pretax Income | -60.56M | -30.7M |
Net Income | -60.56M | -30.7M |
Selling & General & Admin | 7.89M | 4.59M |
Research & Development | 56.14M | 31.81M |
Other Expenses | n/a | n/a |
Operating Expenses | 64.02M | 36.4M |
Interest Expense | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a |
Cost & Expenses | 64.02M | 36.4M |
Income Tax Expense | n/a | n/a |
Shares Outstanding (Basic) | 29.08M | 29.08M |
Shares Outstanding (Diluted) | 29.08M | 29.08M |
EPS (Basic) | -2.08 | -1.06 |
EPS (Diluted) | -2.08 | -1.06 |
EBITDA | -63.58M | -36.05M |
EBIT | -64.02M | -36.4M |
Depreciation & Amortization | 441K | 350K |
Add to Watchlist
Select watchlists to add or remove BLSM